Ninety-day readmissions after cholecystectomy: a 6-year analysis according to previous ERCP performance

Ninety-day readmissions after inpatient cholecystectomy: A 5-year analysis

AIM To determine the incidence of readmission after cholecystectomy using 90 d as a time limit. METHODS We retrospectively reviewed all patients undergoing cholecystectomy at the General Surgery and Digestive System Service of the University Hospital of Guadalajara, Spain. We included all patients undergoing cholecystectomy for biliary pathology who were readmitted to hospital within 90 d. We...

Re: Adverse events and readmissions after day-case urological surgery.

Adverse events and readmissions after day-case urological surgery.

OBJECTIVE The literature lacks of studies on postoperative outcomes after urological ambulatory surgery. Our study aims to identify parameters associated with postoperative complications within 30 days after ambulatory urological surgery. MATERIALS AND METHODS Adjusted and unadjusted comparisons between clinical features and postoperative outcome (complicated and uncomplicated). RESULTS Pos...

Prediction of pneumonia 30-day readmissions: a single-center attempt to increase model performance.

BACKGROUND Existing models developed to predict 30 days readmissions for pneumonia lack discriminative ability. We attempted to increase model performance with the addition of variables found to be of benefit in other studies. METHODS From 133,368 admissions to a tertiary-care hospital from January 2009 to March 2012, the study cohort consisted of 956 index admissions for pneumonia, using the...

Ninety-day mortality after elective total hip replacement: 1549 patients using aspirin as a thromboprophylactic agent.

Thromboprophylaxis after elective orthopaedic surgery remains controversial. Recent guidelines from the National Institute for Clinical Excellence (NICE) have suggested that low molecular weight heparin should be given to all patients undergoing total hip replacement. The British Orthopaedic Association is currently debating this guideline with NICE, as it is not clear whether published evidenc...